Giovanni A. Ferrara
Vorstandsvorsitzender bei Medeor Therapeutics, Inc.
Profil
Giovanni A.
Ferrara currently works at Medeor Therapeutics, Inc., as President & Chief Executive Officer.
Mr. Ferrara also formerly worked at Targanta Therapeutics, Inc., as Chief Executive Officer in 2000, NeuroVia, Inc., as President, Chief Executive Officer & Director, Agilix Corp., as Director, Nucleonics, Inc., as Director, Thesan Pharmaceuticals, Inc., as Director, Burrill LLC, as Managing Director from 2001 to 2009, Spectral Genomics, Inc., as Director, Akebia Therapeutics, Inc., as Director, Sorbent Therapeutics, Inc., as Chief Business Consultant in 2011, Letko Brosseau Investment Management, Inc., as Financial Analyst, GeneChem Management, Inc., as Manager, and Novartis Venture Funds (USA), as Venture Partner from 2011 to 2018.
Mr. Ferrara received his graduate degree and Masters Business Admin degree from McGill University and undergraduate degree from the University of Toronto.
Aktive Positionen von Giovanni A. Ferrara
| Unternehmen | Position | Beginn |
|---|---|---|
Medeor Therapeutics, Inc.
 Medeor Therapeutics, Inc. Medical/Nursing ServicesHealth Services Medeor Therapeutics, Inc. engages in medical industry. It provides services which are dedicated to the discovery, development, and commercialization of transformative and personalized cellular therapeutics. The company was founded by Samuel Strober, Edgar Engleman, Robert Lowsky, and Chih Ping in 2012 and is headquartered in South San Francisco, CA. | Vorstandsvorsitzender | - |
Ehemalige bekannte Positionen von Giovanni A. Ferrara
| Unternehmen | Position | Ende |
|---|---|---|
Novartis Venture Funds (USA)
 Novartis Venture Funds (USA) Investment ManagersFinance Founded in 1996, Novartis Venture Funds (USA) is a venture capital firm located in Cambridge, Massachusetts. The firm is a subsidiary of Switzerland-based Novartis Venture Funds and their ultimate parent is Novartis AG, a Switzerland-based company that engages in the research, development, manufacturing and marketing of healthcare products. Novartis Venture Funds manages the Bermuda domiciled biotechnology venture fund, Novartis BioVentures Ltd | Private Equity Investor | 15.04.2018 |
Sorbent Therapeutics, Inc.
 Sorbent Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Sorbent Therapeutics, Inc. develops therapies for cardiovascular and renal diseases. It focuses on the development of non-absorbed polymeric drugs to satisfy unmet clinical needs in large cardiovascular and renal markets such as heart failure, chronic kidney disease and hypertension. The company was founded by William R. Rajski, Dean Abrassart, Donald W. Joseph and Lee W. Henderson on January 25, 2005 and is headquartered in Sunnyvale, CA. | Corporate Officer/Principal | 31.12.2011 |
Nucleonics, Inc.
 Nucleonics, Inc. Pharmaceuticals: MajorHealth Technology Nucleonics, Inc. develops RNA interference-based therapeutics. It offers DNA vaccine programs. The company was founded in January 2001 and is headquartered in Horsham, PA. | Direktor/Vorstandsmitglied | 04.12.2009 |
Agilix Corp.
 Agilix Corp. Medical SpecialtiesHealth Technology Agilix Corp. develops genomics and proteomics platform technologies for the systematic discovery and analysis of genes, protein products and related biological functions. The company was founded in 1999 and is headquartered in New Haven, CT. | Direktor/Vorstandsmitglied | 05.01.2009 |
Spectral Genomics, Inc.
 Spectral Genomics, Inc. BiotechnologyHealth Technology Spectral Genomics is a biotechnology company that makes DNA microarrays and chips which can be used in cloning and genome profiling. Its arrays are made from bacterial artificial chromosomes (BACs). The company's Spectral Chip and Constitutional Chip are designed to highlight the genome's spots in research. The company supplies BAC clones to university laboratories and biotech and pharmaceutical research and development facilities. Spectral Genomics also sells the SpectralWare Array Analysis System, software designed for use in conjunction with the company's arrays. Spectral Genomics is headquartered in Houston, TX | Direktor/Vorstandsmitglied | 31.07.2007 |
Ausbildung von Giovanni A. Ferrara
| McGill University | Graduate Degree |
| University of Toronto | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| AKEBIA THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 12 |
|---|---|
Agilix Corp.
Agilix Corp. Medical SpecialtiesHealth Technology Agilix Corp. develops genomics and proteomics platform technologies for the systematic discovery and analysis of genes, protein products and related biological functions. The company was founded in 1999 and is headquartered in New Haven, CT. | Health Technology |
Nucleonics, Inc.
Nucleonics, Inc. Pharmaceuticals: MajorHealth Technology Nucleonics, Inc. develops RNA interference-based therapeutics. It offers DNA vaccine programs. The company was founded in January 2001 and is headquartered in Horsham, PA. | Health Technology |
Sorbent Therapeutics, Inc.
Sorbent Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Sorbent Therapeutics, Inc. develops therapies for cardiovascular and renal diseases. It focuses on the development of non-absorbed polymeric drugs to satisfy unmet clinical needs in large cardiovascular and renal markets such as heart failure, chronic kidney disease and hypertension. The company was founded by William R. Rajski, Dean Abrassart, Donald W. Joseph and Lee W. Henderson on January 25, 2005 and is headquartered in Sunnyvale, CA. | Health Technology |
Thesan Pharmaceuticals, Inc.
 Thesan Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Thesan Pharmaceuticals, Inc. provides novel therapeutics for disorders of the skin. The company focuses on the discovery and development of new chemical entities that provide improved treatment options to patients. Thesan Pharmaceuticals was founded in 2011 by Edward P. Monaghan and is headquartered in Carlsbad, CA. | Health Technology |
Burrill LLC
 Burrill LLC Investment ManagersFinance Burril LLC (Burrill) is a private equity/venture capital firm founded in 1994 by G. Steven. The firm is headquartered in San Francisco, California. | Finance |
Letko Brosseau Investment Management, Inc.
 Letko Brosseau Investment Management, Inc. Investment ManagersFinance Founded in 2004, Letko Brosseau Investment Management, Inc. is an SEC-registered investment advisor headquartered in Montréal, Quebec. The firm is a subsidiary of Letko, Brosseau & Associates, Inc. They offer investment advisory services to institutional investors including, but not limited to, pension funds, endowments and foundations, and also to wealthy individuals. | Finance |
Spectral Genomics, Inc.
Spectral Genomics, Inc. BiotechnologyHealth Technology Spectral Genomics is a biotechnology company that makes DNA microarrays and chips which can be used in cloning and genome profiling. Its arrays are made from bacterial artificial chromosomes (BACs). The company's Spectral Chip and Constitutional Chip are designed to highlight the genome's spots in research. The company supplies BAC clones to university laboratories and biotech and pharmaceutical research and development facilities. Spectral Genomics also sells the SpectralWare Array Analysis System, software designed for use in conjunction with the company's arrays. Spectral Genomics is headquartered in Houston, TX | Health Technology |
Targanta Therapeutics, Inc.
 Targanta Therapeutics, Inc. BiotechnologyHealth Technology Targanta Therapeutics, Inc. develops antibiotic drugs and other related products. It focuses on developing and commercializing novel antibacterial agents to address unmet medical needs in the hospital market. The company also develops antibacterial pro-drugs for the treatment and prevention of bone infections. Targanta Therapeutics was founded in May 2007 and is located in St. Laurent, Canada | Health Technology |
GeneChem Management, Inc.
 GeneChem Management, Inc. Investment ManagersFinance GeneChem Management Inc (GeneChem) is an independent venture capital firm founded in 1997. The firm is headquartered in Montréal. | Finance |
Novartis Venture Funds (USA)
Novartis Venture Funds (USA) Investment ManagersFinance Founded in 1996, Novartis Venture Funds (USA) is a venture capital firm located in Cambridge, Massachusetts. The firm is a subsidiary of Switzerland-based Novartis Venture Funds and their ultimate parent is Novartis AG, a Switzerland-based company that engages in the research, development, manufacturing and marketing of healthcare products. Novartis Venture Funds manages the Bermuda domiciled biotechnology venture fund, Novartis BioVentures Ltd | Finance |
NeuroVia, Inc.
 NeuroVia, Inc. Pharmaceuticals: MajorHealth Technology Neurovia, Inc. provides small molecule therapeutics for the treatment of neurologic disorders. The company was founded by Thomas Scanlan in 2014 and is headquartered in Cambridge, MA. | Health Technology |
Medeor Therapeutics, Inc.
Medeor Therapeutics, Inc. Medical/Nursing ServicesHealth Services Medeor Therapeutics, Inc. engages in medical industry. It provides services which are dedicated to the discovery, development, and commercialization of transformative and personalized cellular therapeutics. The company was founded by Samuel Strober, Edgar Engleman, Robert Lowsky, and Chih Ping in 2012 and is headquartered in South San Francisco, CA. | Health Services |
